bpc-157 not approved by fda statement panel backs compounded BPC-157, KPV peptides in win for RFK Jr BPC-157's FDA Review Raises Questions

Current obstacles to successful local or systemic delivery of peptides include poor absorption, enzymatic degradation, and mucociliary clearance

Joey from customer support was helpful and Communication is excellent

[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Han X et al

(2012) "Thymosin 4: a multi-functional regenerative peptide" Expert Opinion on Biological Therapy Bauer & Kamysz (2025) "BPC 157: A Comprehensive Review" MDPI Pharmaceuticals Disclaimer: This article documents statements made on public podcast episodes and summarizes published research

Studies have found mixed results on whether one form is absorbed better or is more effective